. . . "Other Big Pharmas with hundreds of cuts in the news recently include Abbott Laboratories ($ABT) (550 across several business units), Pfizer ($PFE) (300, mostly in sales) and Johnson & Johnson ($JNJ) (130 in Alzheimer's R&D)." .